Subcategory & Sub-subcategory
Product Name
Drug Products
Specifications
- Application: Comprehensive services for formulating new molecular entities and reformulating existing drugs, specialising in sterile, pyrogen-free parenteral formulations for preclinical and clinical trials
- Certification Standard: State-of-the-art facility fully compliant with the latest EU GMP Annex 1 standards for sterile medicinal products, featuring two fully automated production lines for liquid and lyophilized drug products
- Capacity / Throughput: 9,500 m2 facility opened in early 2023 representing a EUR 60 million investment, supporting therapeutic areas including highly potent compounds and antibody-drug conjugates
Leave your rating & comment